• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Bayer

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Data from Phase III study OASIS 3 support efficacy and long-term safety of investigational compound elinzanetant in the treatment of moderate to severe vasomotor symptoms associated with menopause
September 10, 2024
From Bayer
Via Business Wire
News headline image
New results from the Investigational agent BAY 2927088 in HER2-mutant non-small cell lung cancer (NSCLC) presented at WCLC
September 09, 2024
From Bayer
Via Business Wire
News headline image
Bayer to Present New Prostate Cancer Data and Continued Oncology Portfolio Research at ESMO 2024
September 05, 2024
From Bayer
Via Business Wire
News headline image
Bayer to Unveil New Data From Its Phase III OASIS 3 Long-Term Study of Elinzanetant in the Treatment of Vasomotor Symptoms Associated With Menopause
September 04, 2024
From Bayer
Via Business Wire
News headline image
ESC 2024: Late-Breaking KERENDIA® (finerenone) Investigational Data Presented
September 01, 2024
From Bayer
Via Business Wire
News headline image
ESC Congress 2024: Bayer to Present Phase III KERENDIA® (finerenone) Data
August 29, 2024
From Bayer
Via Business Wire
News headline image
Bayer starts Phase III Trial in Non-Small Cell Lung Cancer (NSCLC)
August 29, 2024
From Bayer
Via Business Wire
News headline image
Bayer and NextRNA Therapeutics Enter Strategic Collaboration to Develop Small Molecules Targeting Long Non-Coding RNAs (lncRNAs) in Oncology
August 28, 2024
From Bayer
Via Business Wire
News headline image
Fast, Stable, Secure: New Bayer Hardware Simplifies Farm Activities, Equipment Setup and Provides Increased Value to Farmers
August 26, 2024
From Bayer
Via Business Wire
News headline image
The Journal of American Medical Association (JAMA) publishes Elinzanetant Phase III data
August 22, 2024
From Bayer
Via Business Wire
News headline image
Bayer Initiates Phase II Study of Soluble Guanylate Cyclase Activator (BAY3283142) in Patients With Chronic Kidney Disease
August 22, 2024
From Bayer
Via Business Wire
News headline image
Bayer and Alara Imaging Announce Collaboration
August 05, 2024
From Bayer
Via Business Wire
News headline image
Bayer Announces Primary Endpoint Achieved in Phase III FINEARTS-HF Cardiovascular Outcomes Study Investigating KERENDIA® (finerenone) in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction
August 05, 2024
From Bayer
Via Business Wire
News headline image
Bayer Submits New Drug Application to U.S. FDA for Elinzanetant for the Treatment of Moderate to Severe Vasomotor Symptoms Associated With Menopause
August 01, 2024
From Bayer
Via Business Wire
News headline image
Bayer announces positive topline results for NUBEQA® (darolutamide) from Phase III trial in men with metastatic hormone-sensitive prostate cancer (mHSPC)
July 17, 2024
From Bayer
Via Business Wire
News headline image
Bayer and Kroger Team Up with Luke Bryan and Feeding America to Improve Access to Nutritious Food
July 13, 2024
From Bayer
Via Business Wire
News headline image
One A Day® Launches Science-Backed Cellular Aging Support Supplement
July 09, 2024
From Bayer
Via Business Wire
News headline image
Bayer and Rad AI Announce Collaboration agreement
June 27, 2024
From Bayer
Via Business Wire
News headline image
Reality TV Couple Lauren Speed-Hamilton and Cameron Hamilton Help Daters Keep the FIZZ Alive with NEW Alka-Seltzer® Fizzy Melts
June 18, 2024
From Bayer
Via Business Wire
News headline image
44 Members of Congress Call for Federal Screening Recommendations for Kidney Disease
June 05, 2024
From Bayer
Via Business Wire
News headline image
Elinzanetant significantly reduces frequency and severity of moderate to severe hot flashes associated with menopause
May 16, 2024
From Bayer
Via Business Wire
News headline image
Bayer presents latest data from oncology portfolio at 2024 ASCO Annual Meeting
May 16, 2024
From Bayer
Via Business Wire
News headline image
Bayer Starts Phase I Study With Novel Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer
May 15, 2024
From Bayer
Via Business Wire
News headline image
Study Design and Baseline Characteristics of Prespecified, Exploratory Pooled Analysis to Investigate Effect of Finerenone on Cardio-Kidney Outcomes in Patients with CKD and Type 2 Diabetes and/or Heart Failure Shared at Heart Failure 2024 Congress
May 13, 2024
From Bayer
Via Business Wire
News headline image
One A Day® Partners with Julian Edelman to Share #WellnessConfessionals
May 13, 2024
From Bayer
Via Business Wire
News headline image
Bayer to Present Investigational Data from Comprehensive KERENDIA® (finerenone) Clinical Trial Program at Heart Failure 2024 Congress
May 10, 2024
From Bayer
Via Business Wire
News headline image
WomenHeart and Bayer Join Forces to Enhance Heart Health Awareness and Education Among Women Across the U.S.
May 10, 2024
From Bayer
Via Business Wire
News headline image
Midol® Addresses Period Education and Normalization of Menstrual Discomfort with PeriodTalk Initiative in Partnership with Nonprofit PERIOD.
May 09, 2024
From Bayer
Via Business Wire
News headline image
Bayer to unveil late-breaking data from Phase III OASIS 1 and 2 for elinzanetant in the treatment of vasomotor symptoms associated with menopause
May 08, 2024
From Bayer
Via Business Wire
News headline image
Bayer Introduces Iberogast™ in the U.S., Bringing Proven Plant-Based Relief to the Millions Who Experience Gut Health Issues
April 24, 2024
From Bayer
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap